Molecular cancer therapy for tumor suppressor p53-mutated human Cancers: Cytotoxic diarylheptanoid suppresses the oncogenic function of Mt-p53 (R175H and R273H) via up regulation of its target gene, 2/March/2014, 17.42

Molecular cancer therapy for tumor suppressor p53-mutated human Cancers: Cytotoxic diarylheptanoid suppresses the oncogenic function of Mt-p53 (R175H and R273H) via up regulation of its target gene, 2/March/2014, 17.42

Molecular cancer therapy for tumor suppressor p53-mutated human Cancers: Cytotoxic diarylheptanoid suppresses the oncogenic function of Mt-p53 (R175H and R273H) via up regulation of its target gene, 2/March/2014, 17.42 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To cite: Boominathan, Molecular cancer therapy for tumor suppressor p53-mutated human Cancers: Cytotoxic diarylheptanoid suppresses the oncogenic function of Mt-p53 (R175H and R273H) via up regulation of its target gene, 2/March/2014, 17.42,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Share
Start Typing